Catalyst Pharmaceuticals, Inc. (CPRX)
22.96
-0.21
(-0.91%)
USD |
NASDAQ |
Jan 15, 16:00
22.97
+0.01
(+0.04%)
After-Hours: 20:00
Catalyst Pharmaceuticals SG&A Expense (TTM): 162.44M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Collegium Pharmaceutical, Inc. | 280.25M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Amicus Therapeutics, Inc. | 353.07M |
| Rigel Pharmaceuticals, Inc. | 115.43M |
| Krystal Biotech, Inc. | 136.75M |